MECP2 and Parkinson disease: ChIP assays of the subregions in SNCA intron 1, ChIP1 and ChIP2, showed a trend towards reduced binding of MeCP2 in PD compared to healthy controls, but again, the small group numbers prevented statistical analysis (Fig. 2F).